COMMUNIQUÉS West-GlobeNewswire

Philips Annual General Meeting of Shareholders re-appoints CEO Frans van Houten and CFO Abhijit Bhattacharya

09/05/2019 - 16:00

May 9, 2018 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (AGM) re-appointed Frans van Houten as President/CEO and member of the Board of [...]

Driven Deliveries Inc. Receives New Delivery License, Significantly Expands California Footprint

09/05/2019 - 16:00

Driven Deliveries to serve 92% of California’s cannabis market SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (OTC:DRVD), the first and only cannabis delivery company to be publicly traded on a [...]

Sienna Biopharmaceuticals to Present at BAML Health Care Conference

09/05/2019 - 15:05

WESTLAKE VILLAGE, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna, [...]

Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares

09/05/2019 - 15:00

FREMONT, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has issued and sold an additional 750,000 shares of common [...]

Aptevo Therapeutics Reports First Quarter 2019 Financial Results

09/05/2019 - 15:00

Achieves 73% Increase in First Quarter 2019 Year-Over-Year IXINITY® Net Revenue On Target for Launch of New 3,000 IU IXINITY Assay Mid-2019 Advances Enrollment in APVO436 and APVO210 Phase 1 Clinical Studies; [...]

AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

09/05/2019 - 15:00

Leading cannabinoid biotechnology company files U.S. provisional patent application on a chewing gum composition comprising cannabinoids and feverfew extract for the treatment of symptoms that accompany migraines NEW [...]

Predictive Technology Group Finalizes Board Committee Chair Appointments

09/05/2019 - 15:00

SALT LAKE CITY , May 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through [...]

GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019

09/05/2019 - 14:35

LONDON, May 09, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and [...]

American Cannabis Company, Inc. Provides Company Update On Overall Progress & Recent Activities

09/05/2019 - 14:30

DENVER, CO, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, wishes to [...]

Harpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

09/05/2019 - 14:30

Continued enrollment of Phase 1 trial for HPN424, Harpoon’s lead TriTAC product candidate in development for the treatment of prostate cancer Net proceeds of approximately $71 million from completion of initial public [...]

Bellerophon Provides Business Update and Reports First Quarter 2019 Financial Results

09/05/2019 - 14:30

WARREN, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]

Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference

09/05/2019 - 14:30

BEDFORD, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will participate during a fireside chat at the 2019 Bank of [...]

Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies

09/05/2019 - 14:30

NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out Promise for Patients.” To [...]

Fluidigm to Participate in Upcoming Health Care Investor Conferences

09/05/2019 - 14:30

SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]

Crown Bioscience Announces San Diego, CA Site Expansion

09/05/2019 - 14:30

International Center of Excellence for oncology biomarker and inflammation translational services created SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019

09/05/2019 - 14:22

Bagsværd, Denmark, 9 May 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]

ChromaDex Announces $10 Million Issuance of Convertible Notes

09/05/2019 - 14:20

Private Placement Led by High Profile Venture Capitalists and Strategic Investors LOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has entered into a note purchase [...]

Better Choice Company Continues Expansion into Latin America through MOU for Supply of CBD in Uruguay

09/05/2019 - 14:08

NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (the “Company”) is pleased to announce that it has signed a memorandum of understanding (“MOU”) with Terrace Inc. (“Terrace”) for the [...]

Avid Bioservices Reaffirms Fiscal 2019 Guidance and Announces Upcoming Conference Participation

09/05/2019 - 14:05

TUSTIN, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]